DK0824350T3 - Anvendelse af et antimykotikum - Google Patents

Anvendelse af et antimykotikum

Info

Publication number
DK0824350T3
DK0824350T3 DK96919769T DK96919769T DK0824350T3 DK 0824350 T3 DK0824350 T3 DK 0824350T3 DK 96919769 T DK96919769 T DK 96919769T DK 96919769 T DK96919769 T DK 96919769T DK 0824350 T3 DK0824350 T3 DK 0824350T3
Authority
DK
Denmark
Prior art keywords
pct
date nov
azole
sec
inhibitor
Prior art date
Application number
DK96919769T
Other languages
Danish (da)
English (en)
Inventor
Josef Gottfried Meingassner
Neil Stewart Ryder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0824350T3 publication Critical patent/DK0824350T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
DK96919769T 1995-05-12 1996-05-10 Anvendelse af et antimykotikum DK0824350T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination
PCT/EP1996/002022 WO1996035423A1 (en) 1995-05-12 1996-05-10 Antifungal composition

Publications (1)

Publication Number Publication Date
DK0824350T3 true DK0824350T3 (da) 2003-11-03

Family

ID=10774361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919769T DK0824350T3 (da) 1995-05-12 1996-05-10 Anvendelse af et antimykotikum

Country Status (26)

Country Link
US (1) US5985906A (ko)
EP (1) EP0824350B1 (ko)
JP (1) JPH11504931A (ko)
KR (1) KR100443535B1 (ko)
CN (1) CN1100539C (ko)
AT (1) ATE246504T1 (ko)
AU (1) AU712914B2 (ko)
CA (1) CA2219651C (ko)
CY (1) CY2496B1 (ko)
CZ (1) CZ291144B6 (ko)
DE (1) DE69629367T2 (ko)
DK (1) DK0824350T3 (ko)
ES (1) ES2205042T3 (ko)
FI (1) FI120079B (ko)
GB (1) GB9509631D0 (ko)
HK (1) HK1016064A1 (ko)
HU (1) HU224920B1 (ko)
IL (2) IL118219A0 (ko)
MX (1) MX9708699A (ko)
NO (1) NO317030B1 (ko)
PL (1) PL322749A1 (ko)
PT (1) PT824350E (ko)
SK (1) SK150797A3 (ko)
TW (1) TW464492B (ko)
WO (1) WO1996035423A1 (ko)
ZA (1) ZA963754B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
AU783158B2 (en) * 1999-08-24 2005-09-29 Ariad Pharmaceuticals, Inc. 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
DE602004028284D1 (de) 2003-12-08 2010-09-02 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
RU2396955C2 (ru) 2005-04-07 2010-08-20 Тояма Кемикал Ко., Лтд. Фармацевтическая комбинация и способ применения противогрибкового средства в комбинации
EP2070536B1 (en) 2006-10-06 2011-12-28 Toyama Chemical Co., Ltd. Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent
US20080167312A1 (en) * 2006-12-08 2008-07-10 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
US8921642B2 (en) 2008-01-11 2014-12-30 Massachusetts Eye And Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
US9593356B2 (en) 2013-06-11 2017-03-14 Takara Bio Usa, Inc. Protein enriched microvesicles and methods of making and using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ

Also Published As

Publication number Publication date
IL118219A (en) 2001-08-26
AU5818396A (en) 1996-11-29
PT824350E (pt) 2003-12-31
CA2219651C (en) 2007-03-27
ZA963754B (en) 1997-11-10
CY2496B1 (en) 2005-09-02
CZ291144B6 (cs) 2002-12-11
HUP9801140A2 (hu) 1999-01-28
SK150797A3 (en) 1998-05-06
NO975134L (no) 1997-11-07
CZ354797A3 (cs) 1998-02-18
AU712914B2 (en) 1999-11-18
DE69629367D1 (de) 2003-09-11
ATE246504T1 (de) 2003-08-15
FI973812A0 (fi) 1997-09-26
TW464492B (en) 2001-11-21
NO975134D0 (no) 1997-11-07
MX9708699A (es) 1998-02-28
CN1184427A (zh) 1998-06-10
IL118219A0 (en) 1996-09-12
ES2205042T3 (es) 2004-05-01
EP0824350A1 (en) 1998-02-25
NO317030B1 (no) 2004-07-26
HUP9801140A3 (en) 2000-07-28
EP0824350B1 (en) 2003-08-06
CN1100539C (zh) 2003-02-05
KR19990014708A (ko) 1999-02-25
US5985906A (en) 1999-11-16
GB9509631D0 (en) 1995-07-05
WO1996035423A1 (en) 1996-11-14
JPH11504931A (ja) 1999-05-11
CA2219651A1 (en) 1996-11-14
HK1016064A1 (en) 1999-10-29
DE69629367T2 (de) 2004-06-09
PL322749A1 (en) 1998-02-16
HU224920B1 (en) 2006-04-28
FI120079B (fi) 2009-06-30
FI973812A (fi) 1997-11-11
KR100443535B1 (ko) 2004-12-17

Similar Documents

Publication Publication Date Title
DK0824350T3 (da) Anvendelse af et antimykotikum
DK1355889T3 (da) Substituerede triazoldiaminderivater som kinaseinhibitorer
DE60130555D1 (de) 1-(heteroaryl-phenyl)-kondensierte pyrazol-derivate als factor xa inhibitoren
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
DE69611512T2 (de) Pyrimidonderivate mit antifungaler wirkung
DE69431194D1 (de) Amidino-derivate nützlich als no synthase-hemmer
NO973857L (no) 1-aryl-2-acylamino-etanforbindelser og deres anvnedelse som neurokinin-, spesielt neurokinin-1-antagonister
DE69616340D1 (de) Fungizide mischungen
DK1235579T3 (da) Farmaceutiske præparater med indhold af trimegeston
ATE361898T1 (de) Verwendung von ozonierten lösungen von tetrasilber tetraoxide
ES2136615T3 (es) Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos.
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool
NO975084D0 (no) Bakteriostatisk preparat og dets anvendelse i metallbearbeidingsfluider
SE9402241L (sv) Inhibitor
SE9404438D0 (sv) New process
ITMI20000908A0 (it) Metodo e sistema per l'assicurazione di un investimento in titoli azionari e similari.